FIELD: medicine.
SUBSTANCE: method involves application of a xenograft model in vivo. Tumour fragments isolated from the patient are used as the transplant. Transplantation performed in the anterior chamber of the rabbit's eye. Doxorubicin or cisplatin are used as chemotherapeutic agents. Constant visual assessment of transplanted cells response to the action of cytostatics is carried out, in particular, continuous analysis of photos of the transplanted tumour.
EFFECT: ability to monitor the processes in the tumour in real time, and react promptly by adjusting treatment.
9 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOR COMPOSITION OF DOXORUBICIN WITH ATP INHIBITOR-DEPENDENT REVERSE CELL TRANSPORTER | 2018 |
|
RU2680834C1 |
| METHOD FOR POTENTIATING ACTIVITY OF ANTI-TUMOUR CYTOTOXIC PREPARATIONS | 2017 |
|
RU2714140C2 |
| PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
| SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
| METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
| METHOD OF TREATING ASCITIC CARCINOMA | 2015 |
|
RU2595864C1 |
| ANTITUMOR CHEMICAL PREPARATION | 2016 |
|
RU2629608C1 |
| COMPOSITION FOR KILLING TNF-α-SENSITIVE TUMOR CELLS | 2002 |
|
RU2209078C1 |
| HUMAN BREAST CANCER CELL LINE BrCCh4e | 2019 |
|
RU2717654C1 |
| METHOD FOR TUMOUR GROWTH INHIBITION | 2010 |
|
RU2446844C1 |
